Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis-Reference-Cited by-同舟云学术

Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis

Published:2020-03-23 Issue:8 Volume:42 Page:2067-2076
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

He Yan¹^ORCID,Zhao Zhihao²,Wang Ying³,Chai Jiamin²,He Jialing¹,Wang Jingjing¹^ORCID,He Ling¹,Guan Hui¹^ORCID,Wei Zhigong¹,Liu Zheran¹^ORCID,Mu Xiaoli¹,Peng Xingchen¹^ORCID

Affiliation:

1. Department of Biotherapy, Cancer Center, West China HospitalSichuan University Chengdu China

2. West China School of Basic Medical Sciences and Forensic MedicineSichuan University Chengdu China

3. Geriatrics Center, West China HospitalSichuan University Chengdu China

Funder

National Natural Sciences Foundation of China

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26141

Reference23 articles.

1. Global cancer statistics, 2012

2. Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker

3. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

4. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era

5. Nasopharyngeal carcinoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of waiting time for radiotherapy after last induction chemotherapy on prognosis of locally advanced nasopharyngeal carcinoma;Head & Neck;2024-02-17

2. The optimum number of induction chemotherapy cycles for N3M0 stage nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA;2023-08-31

3. Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-07

4. Carcinoma rinofaringeo. Un tumore della testa e collo “diverso”. Parte B: trattamento, fattori prognostici e risultati a distanza;Acta Otorhinolaryngologica Italica;2023-06

5. Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database;Medicine;2023-05-12